Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-Blinded, Randomized Clinical Trial

Cancer Prevention Research · Published 2026-03-07 · DOI 10.1158/1940-6207.capr-25-0364

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1158/1940-6207.capr-25-0364

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Molecular Cancer Signal Localization in MCED Testing Minimizes Radiation and Imaging Burden Compared with Whole-body Imaging Approaches · Cancer Prevention Research · 2026 · Same journal
• The Long and Winding Road toward Prevention of Estrogen Receptor–Negative and BRCA1-Associated Breast Cancer · Cancer Prevention Research · 2026 · Same journal
• Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis · Cancer Prevention Research · 2026 · Same journal
• Appetite, Obesity, Metabolism, and Malignancy: Do Incretin-Mimetic Drugs Reduce Cancer Risk? · Cancer Prevention Research · 2026 · Same journal
• The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial · Cancer Prevention Research · 2026 · Same journal
• Editors’ Selections from Relevant Scientific Publications · Cancer Prevention Research · 2026 · Same journal
• Pattern-based p53 and p16 Immunohistochemistry as a Potential Alternative to Loss of Heterozygosity Testing for Progression Risk of Oral Epithelial Dysplasia · Cancer Prevention Research · 2025 · Same journal
• Editors’ Selections from Relevant Scientific Publications · Cancer Prevention Research · 2026 · Same journal
• Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer · Cancer Prevention Research · 2025 · Same journal
• Reprogramming the Course of Precancer with Targeted Therapeutic Intervention: Lessons from Interception in Gastric Preneoplasia · Cancer Prevention Research · 2025 · Same journal